You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

pregabalin sustained release tablet

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neuropathic Pain, Diabetes, Type 2 Trial in Korea, Republic of (pregabalin sustained release tablet, pregabalin immediate

Active, not recruiting
  • Neuropathic Pain
  • Diabetes Mellitus, Type 2
  • pregabalin sustained release tablet
  • pregabalin immediate release capsule
  • Cheongju, Chungcheongbuk-do, Korea, Republic of
  • +7 more
Nov 14, 2022

Generalized Anxiety Disorder Trial in Beijing (Toludesvenlafaxine Hydrochloride Sustained-release Tablet 80mg,

Not yet recruiting
  • Generalized Anxiety Disorder
  • Toludesvenlafaxine Hydrochloride Sustained-release Tablet 80mg
  • +2 more
  • Beijing, China
    Peking University Sixth Hospital
Aug 1, 2023

Partial Seizure Trial in Tianjin (Brivaracetam tablets (50mg/ tablet, BRIVIACT®, UCB), Brivaracetam sustained-release tablets

Active, not recruiting
  • Partial Seizure
  • Brivaracetam tablets (50mg/ tablet, BRIVIACT®, UCB)
  • +2 more
  • Tianjin, Tianjin, China
    Tianjin Municipal People's Hospital
Jan 31, 2023

Idiopathic Pulmonary Fibrosis Trial in Cincinnati (Esbriet 267 MG Oral Capsule, EXCL-100, 600 MG Oral Tablet)

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • Esbriet 267 MG Oral Capsule
  • EXCL-100, 600 MG Oral Tablet
  • (no location specified)
Jun 24, 2022

Huntington Disease, Tardive Dyskinesia Trial in Shanghai (LPM3770164 sustained release tablet, LPM3770164 sustained release

Not yet recruiting
  • Huntington Disease
  • Tardive Dyskinesia
  • LPM3770164 sustained release tablet
  • LPM3770164 sustained release tablet simulant
  • Shanghai, Shanghai, China
    Shanghai Mental Health Center
Feb 3, 2022

MDD Trial in Beijing (Desvenlafaxine Succinate Sustained-Release Tablet , Duloxetine Hydrochloride Enteric-coated Capsule

Completed
  • Major Depressive Disorder
  • Desvenlafaxine Succinate Sustained-Release Tablet , Duloxetine Hydrochloride Enteric-coated Capsule Placebo
  • +3 more
  • Beijing, China
    Beijing Anding Hospital
Dec 1, 2021

Essential Hypertension Trial (Azilsartan Medoxomil Potassium Tablet, Nifedipine Sustained -release Tablets, Levoamlodipine

Not yet recruiting
  • Essential Hypertension
  • Azilsartan Medoxomil Potassium Tablet
  • +2 more
  • (no location specified)
Jul 21, 2023

Pain Trial (Tramadol HCI/Acetaminophen)

Completed
  • Pain
  • Tramadol HCI/Acetaminophen
  • (no location specified)
Apr 29, 2021

Healthy Trial in Bruxelles (Pregabalin controlled release, 82.5 mg, Pregabalin immediate release, 25 mg)

Completed
  • Healthy
  • Pregabalin controlled release, 82.5 mg
  • Pregabalin immediate release, 25 mg
  • Bruxelles, Belgium
    Pfizer Investigational Site
Jan 21, 2021

Healthy Trial in Bruxelles (Pregabalin immediate release, 300 mg, Pregabalin controlled release, 330 mg)

Completed
  • Healthy
  • Pregabalin immediate release, 300 mg
  • Pregabalin controlled release, 330 mg
  • Bruxelles, Belgium
    Pfizer Investigational Site
Jan 21, 2021

Healthy Trial in Overland Park (Pregabalin controlled release, 330 mg, 400 to 500 calories, Pregabalin controlled release, 330

Completed
  • Healthy
  • Pregabalin controlled release, 330 mg, 400 to 500 calories
  • +3 more
  • Overland Park, Kansas
    Pfizer Investigational Site
Jan 21, 2021

Healthy Trial in New Haven (Pregabalin controlled release, 330 mg, 600- 750 calorie, Pregabalin controlled release, 330 mg,

Completed
  • Healthy
  • Pregabalin controlled release, 330 mg, 600- 750 calorie
  • +2 more
  • New Haven, Connecticut
    Pfizer Investigational Site
Jan 21, 2021

Healthy Trial in Overland Park (Pregabalin controlled release, 330 mg, low-fat, Pregabalin controlled release, 330 mg,

Completed
  • Healthy
  • Pregabalin controlled release, 330 mg, low-fat
  • +3 more
  • Overland Park, Kansas
    Pfizer Investigational Site
Jan 20, 2021

Healthy Trial in Bruxelles (Pregabalin controlled release, 330 mg, erythromycin)

Completed
  • Healthy
  • Bruxelles, Belgium
    Pfizer Investigational Site
Jan 21, 2021

Healthy Trial in New Haven (Pregabalin controlled release, 330 mg, 400 to 500 calorie, Pregabalin controlled release, 330 mg,

Completed
  • Healthy
  • Pregabalin controlled release, 330 mg, 400 to 500 calorie
  • +3 more
  • New Haven, Connecticut
    Pfizer Investigational Site
Jan 21, 2021

Healthy Trial in Bruxelles (Sequence 1 - Treatment A: Controlled Release Pregabalin, Sequence 1 - Treatment B: Controlled

Completed
  • Healthy
  • Sequence 1 - Treatment A: Controlled Release Pregabalin
  • +19 more
  • Bruxelles, Belgium
    Pfizer Investigational Site
Jan 20, 2021

Tourette Syndrome Trial in Chicago, Manhasset (SNC-102 sustained release tablet)

Withdrawn
  • Tourette Syndrome
  • SNC-102 sustained release tablet
  • Chicago, Illinois
  • +1 more
Apr 8, 2021

Type 2 Diabetes Trial in Nakhon Pathom (Gemigliptin tartrate sesquihydrate and metformin, gemigliptin 50 mg and metformin HCl

Completed
  • Type 2 Diabetes
  • Gemigliptin tartrate sesquihydrate and metformin
  • gemigliptin 50 mg and metformin hydrochloride 1000 mg prolonged release
  • Nakhon Pathom, Thailand
    International Bio Service Co., Ltd.
Feb 4, 2021

Parkinson's Disease Trial in Hanzhou (Praxol HCl sustained release tablet Specification: 0.375mg/ tablet (in pramipexole HCl),

Unknown status
  • Parkinson's Disease
  • Praxol hydrochloride sustained release tablet Specification: 0.375mg/ tablet (in pramipexole hydrochloride)
  • Pramipexole hydrochloride sustained-release tablet (Siforl®) Specification: 0.26mg/ tablet (in pramipexole)
  • Hanzhou, Zhejiang, China
    The First Affiliated Hospital,ZheJiang Univercity
Sep 7, 2020

Cerebral Small Vessel Diseases Trial in Beijing (Pentoxifylline sustained-release tablets, Pentoxifylline sustained-release

Not yet recruiting
  • Cerebral Small Vessel Diseases
  • Pentoxifylline sustained-release tablets
  • Pentoxifylline sustained-release tablets placebo
  • Beijing, China
    Beijing Tiantan Hospital
Oct 13, 2022

Healthy Trial in Merksem (Selexipag matrix tablet, Selexipag encapsulated pellets, Selexipag Immediate-release (IR) tablet)

Completed
  • Healthy
  • Selexipag matrix tablet
  • +2 more
  • Merksem, Belgium
    Clinical Pharmacology Unit
Sep 7, 2020

Opioid-induced Respiratory Depression Trial in Leiden (Pregabalin 150mg, Oxycodone 10mg, Lacosamide 150 mg)

Recruiting
  • Opioid-induced Respiratory Depression
  • Pregabalin 150mg
  • +2 more
  • Leiden, ZH, Netherlands
    Leiden University Medical Center
Dec 9, 2022

Oxaliplatin Induced Peripheral Neuropathy in Cancer Patients Trial in Dhaka (lidocaine transdermal patch)

Recruiting
  • Oxaliplatin Induced Peripheral Neuropathy in Cancer Patients
  • lidocaine transdermal patch
  • Dhaka, Bangladesh
    Bangabandhu Sheikh Mujib Medical University
May 22, 2023

Hypertension Trial in Dongguan (Felodipine sustained release tablets (trade name: plendil®), Felodipine Controlled Release

Active, not recruiting
  • Hypertension
  • Felodipine sustained release tablets (trade name: plendil®)
  • Felodipine Controlled Release Tablets
  • Dongguan, Guangdong, China
    Clinical Trial Centre of Dongguan Kanghua Hospital
Jan 31, 2023

Healthy Trial in New Haven (Pregabalin ER)

Completed
  • Healthy
  • Pregabalin ER
  • New Haven, Connecticut
    Pfizer New Haven Clinical Research Unit
Jan 15, 2021